Elevated levels of serum chemerin in patients with obstructive sleep apnea syndrome

References

• Acioglu E, Yigit O, Volkan Sunter A, Taskin U, Berçik Inal B, Sahin M. (2010). Obesity and obstructive sleep apnea syndrome. J Otolaryngol Head Neck Surg 39:744–751.
   PubMed Web of Science ®Google Scholar
• Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C. (2011). Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 6:120–125.
   PubMed Web of Science ®Google Scholar
• Berg V, Sveinbjörnsson B, Bendiksen S, Brox J, Meknas K, Figenschau Y. (2010). Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21-157). Arthritis Res Ther 12:R228.
   PubMed Web of Science ®Google Scholar
• Bhushan B, Guleria R, Misra A, Luthra K, Vikram NK. (2009). TNF-α gene polymorphism and TNF-α levels in obese Asian Indians with obstructive sleep apnea. Respir Med 103:386–392.
   PubMed Web of Science ®Google Scholar
• Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D. (2007). Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148:4687–4694.
   PubMed Web of Science ®Google Scholar
• Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, Mahaney MC, Rainwater DL, VandeBerg JL, MacCluer JW, Collier G, Blangero J, Walder K, Jowett JB. (2009). Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 94:3085–3088.
   PubMed Web of Science ®Google Scholar
• Deegan PC, McNicholas WT. (1995). Pathophysiology of obstructive sleep apnoea. Eur Respir J 8:1161–1178.
   PubMed Web of Science ®Google Scholar
• Dong B, Ji W, Zhang Y. (2011). Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 50:1093–1097.
   PubMed Web of Science ®Google Scholar
• Dupont WD, Plummer WD Jr. (1990). Power and sample size calculations. A review and computer program. Control Clin Trials 11:116–128.
   PubMedGoogle Scholar
• Eisinger K, Bauer S, Schäffler A, Walter R, Neumann E, Buechler C, Müller-Ladner U, Frommer KW. (2011). Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp Mol Pathol 92:90–96.
   PubMed Web of Science ®Google Scholar
• Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ. (2007). Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282:28175–28188.
   PubMed Web of Science ®Google Scholar
• Hart R, Greaves DR. (2010). Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 185:3728–3739.
   PubMed Web of Science ®Google Scholar
• Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, Eich D, Rössler W, Angst J. (2004). The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 27:661–666.
   PubMed Web of Science ®Google Scholar
• Hu W, Feng P. (2011). Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract 91:159–163.
   PubMed Web of Science ®Google Scholar
• Kent BD, Ryan S, McNicholas WT. (2011). Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 178:475–481.
   PubMed Web of Science ®Google Scholar
• Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, Lebherz C, Tittus J, Reiser M, Becker C, Göke B, Leber AW, Parhofer KG, Broedl UC. (2009). Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 161:339–344.
   PubMed Web of Science ®Google Scholar
• Lurie A. (2011). Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv Cardiol 46:1–42.
   PubMedGoogle Scholar
• Madani M, Madani F. (2009). Epidemiology, pathophysiology, and clinical features of obstructive sleep apnea. Oral Maxillofac Surg Clin North Am 21:369–375.
   PubMed Web of Science ®Google Scholar
• Malhotra A, White DP. (2002). Obstructive sleep apnoea. Lancet 360:237–245.
   PubMed Web of Science ®Google Scholar
• Masserini B, Morpurgo PS, Donadio F, Baldessari C, Bossi R, Beck-Peccoz P, Orsi E. (2006). Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 29:700–705.
   PubMed Web of Science ®Google Scholar
• Pack AI. (2006). Advances in sleep-disordered breathing. Am J Respir Crit Care Med 173:7–15.
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. (2000). Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284:3015–3021.
   PubMed Web of Science ®Google Scholar
• Punjabi NM. (2008). The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5:136–143.
   PubMedGoogle Scholar
• Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M, Sasaki S. (2007). Chemerin – a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 362:1013–1018.
   PubMed Web of Science ®Google Scholar
• Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. (2010). Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 137:711–719.
   PubMed Web of Science ®Google Scholar
• Stejskal D, Karpisek M, Hanulova Z, Svestak M. (2008). Chemerin is an independent marker of the metabolic syndrome in a Caucasian population – a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:217–221.
   PubMed Web of Science ®Google Scholar
• Sunitha C, Aravindkumar S. (2009). Obstructive sleep apnea: clinical and diagnostic features. Indian J Dent Res 20:487–491.
   PubMedGoogle Scholar
• Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer MN, Schäffler A, Aslanidis C, Schölmerich J, Buechler C. (2010). Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 72:342–348.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, Axelsson J. (2010). Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant 25:4017–4023.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Fujiuchi S, Hiramatsu M, Nishigaki Y, Takeda A, Fujita Y, Yamazaki Y. (2008). Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 76:377–385.
   PubMed Web of Science ®Google Scholar
• Ye J, Liu H, Li Y, Liu X, Zhu JM. (2007). Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin Med J 120:1482–1486.
   PubMed Web of Science ®Google Scholar